Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Your search for neuropathic%20pain returned no results
Showing 16 to 30 of 66 results for neuropathic

  1. Neuropathic pain relief:- Does early treatment with a centrally acting analgesic (for example pregabalin) reduce the frequency or severity of neuropathic pain in people with spinal cord injury?

    Recommendation ID NG41/1 Question Neuropathic pain relief:- Does early treatment with a centrally acting analgesic (for example...

    Research recommendation
    Published
    4 April 2016

  2. Monotherapy versus combination therapy for treating neuropathic pain:- What is the clinical effectiveness, cost effectiveness and tolerability of pharmacological monotherapy compared with combination therapy for treating neuropathic pain?

    Question Monotherapy versus combination therapy for treating neuropathic pain:- What is the clinical effectiveness, cost effectiveness...

    Research recommendation
    Published
    9 June 2015

  3. Is there a potential for dependence associated with pharmacological agents for neuropathic pain?

    a potential for dependence associated with pharmacological agents for neuropathic pain? Any explanatory notes(if applicable) There has...

    Research recommendation
    Published
    26 October 2020

  4. How should the symptomatic treatment of neuropathic pain relate to its cause?

    CG173/7 Question How should the symptomatic treatment of neuropathic pain relate to its cause? Any explanatory notes(if applicable)

    Research recommendation
    Published
    26 October 2020

  5. Low-level laser therapy (photobiomodulation) for oral neuropathic pain

    Register an interest in this interventional procedure   ...

    Interventional procedures guidance
    Topic selection

  6. Does early intervention to treat neuropathic pain reduce the likelihood of chronic pain?

    ID CG173/8 Question Does early intervention to treat neuropathic pain reduce the likelihood of chronic pain? Any explanatory notes(if

    Research recommendation
    Published
    26 October 2020

  7. What is the impact of drug-related adverse effects on health economics and quality of life in neuropathic pain?

    and quality of life in neuropathic pain? Any explanatory notes(if applicable) Pharmacological agents for neuropathic pain...

    Research recommendation
    Published
    26 October 2020

  8. What are the key factors, including additional care and support, that influence participation* and quality of life in people with neuropathic pain?

    support, that influence participation* and quality of life in people with neuropathic pain? Any explanatory notes(if applicable) * The...

    Research recommendation
    Published
    26 October 2020

  9. What is the clinical effectiveness, cost effectiveness and tolerability of pharmacological monotherapy compared with combination therapy for treating neuropathic pain?

    pharmacological monotherapy compared with combination therapy for treating neuropathic pain? Any explanatory notes(if applicable) Why...

    Research recommendation
    Published
    26 October 2020

  10. Spinal cord stimulator implantation: Improving theatre efficiency

    cord stimulation system for delivering HF10 therapy to treat chronic neuropathic pain (MTG41)

    Shared learning
    Published
    2 July 2020

  11. Head and neck cancer (QS146)

    This quality standard covers assessing, diagnosing and managing head and neck cancer, including cancer of the upper aerodigestive tract in people aged 16 and over. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    3 March 2017
    View quality statements

    Sections for QS146

  12. Factors affecting participation and quality of life:- What are the key factors, including additional care and support, that influence participation and quality of life in people with neuropathic pain?

    support, that influence participation and quality of life in people with neuropathic pain? Any explanatory notes(if applicable) Why this...

    Research recommendation
    Published
    9 June 2015

  13. Relationship between symptoms, cause of neuropathic pain and its treatment:- Is response to pharmacological treatment predicted more reliably by underlying aetiology or by symptom characteristics?

    CG173/2 Question Relationship between symptoms, cause of neuropathic pain and its treatment:- Is response to pharmacological treatment...

    Research recommendation
    Published
    9 June 2015

  14. Differential target multiplexed spinal cord stimulation for chronic lower back and leg pain (MIB305)

    NICE has developed a medtech innovation briefing (MIB) on differential target multiplexed spinal cord stimulation for chronic lower back and leg pain .

    Medtech innovation briefing
    Published
    30 August 2022

  15. Diabetes: annual examination of foot sensation (IND160)

    This indicator covers the percentage of patients with diabetes with a record of testing of foot sensation using a 10 g monofilament within the preceding 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM131

    General practice indicators suitable for use in QOF
    Last updated
    4 November 2020